Physician-Led Research Infrastructure in a Private Equity–Backed Musculoskeletal Network: An Organizational Case Study
Background: Clinical research programs are often described from the perspective of academic departments with established infrastructure. In contrast, large private musculoskeletal practice networks face a different challenge: how to build a durable research structure while maintaining high-volume clinical operations, distributed leadership, and day-to-day practice efficiency.Objective: To describe an early-stage model for building a clinical research structure within a busy physician-led musculoskeletal practice network and to identify the operational, governance, and partnership strategies used to make research feasible in routine practice, including how physician decision-making authority over research was structured within a private equity–backed management services organization. Methods: This descriptive organizational case study drew on a 2024–2025 clinical research infrastructure assessment, including document review, semi-structured interviews with 12 UMP leaders, and two site visits, together with a structured, iterative review of internal strategic planning materials, leadership presentations, quality and patient-reported outcome (PRO) dashboards, and organizational documents from United Musculoskeletal Partners (UMP), interpreted against prior literature on orthopaedic research team development. Interpretations were checked through author consensus and face-validity review by market-level leaders.Results: UMP’s emerging model rests on five practical design choices: 1) starting with a focused research vision tied to patient outcomes and quality benchmarks; 2) placing physician leadership at the center of governance; 3) using external partners strategically to supplement internal capacity; 4) integrating research activities with existing clinical and operational workflows rather than creating a parallel academic structure; and 5) sequencing the work into short-term proof-of-concept projects and longer-term infrastructure building. Participation grew from a three-person founding team to 21 surgeons serving on a cross-site research council without additional compensation. Existing PRO infrastructure had captured 2,721,144 PRO scores by June 2026, with 2025 baseline compliance of 77.23% across participating practices.Conclusion: For high-volume musculoskeletal groups, durable research infrastructure may be most feasible when built as an extension of clinical operations rather than as a separate academic enterprise. A pragmatic, partnership-enabled, physician-led model may allow busy practice networks to generate publishable data, strengthen quality measurement, and create a sustainable pathway toward broader participation in innovation and clinical trials. Within a private equity–backed platform, documented governance preserved physician authority over research priorities, offering a counterexample to the assumption that such ownership necessarily limits physician direction of research.
Authors
- Tesheia Johnson (ORCID: https://orcid.org/0009-0002-0675-8771)
- Gary W. Stewart
- Kenneth Ellinger
- Melissa Murphy
Publication Details
- Journal
- SocArXiv (OSF Preprints)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.31235/osf.io/7ftje
- Primary Topic
- Health and Medical Research Impacts
- Type
- preprint